KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Long-Term Debt Repayments (2016 - 2023)

Chemed (CHE) has 11 years of Long-Term Debt Repayments data on record, last reported at $76.2 million in Q1 2023.

  • For Q1 2023, Long-Term Debt Repayments fell 11.85% year-over-year to $76.2 million; the TTM value through Mar 2023 reached $296.6 million, up 168.86%, while the annual FY2022 figure was $306.8 million, 1112.65% up from the prior year.
  • Long-Term Debt Repayments reached $76.2 million in Q1 2023 per CHE's latest filing, up from $7.4 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $176.8 million in Q2 2022 and bottomed at $7.4 million in Q4 2022.
  • Average Long-Term Debt Repayments over 5 years is $96.2 million, with a median of $108.4 million recorded in 2019.
  • Peak YoY movement for Long-Term Debt Repayments: surged 207.64% in 2019, then plummeted 68.91% in 2022.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $122.2 million in 2019, then skyrocketed by 31.59% to $160.8 million in 2020, then crashed by 85.2% to $23.8 million in 2021, then tumbled by 68.91% to $7.4 million in 2022, then surged by 930.41% to $76.2 million in 2023.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Repayments were $76.2 million in Q1 2023, $7.4 million in Q4 2022, and $36.1 million in Q3 2022.